secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K
Filed at:   2025-02-11T23:59:59+00:00
Accession:  0001104659-25-011543
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience shareholders approve 100M share increase, equity plan amendment
--------------------------------------------------------------------------------

- Shareholders approved increase in authorized common stock by 100,000,000 shares (Proposal Five).
- Amendment and restatement of 2018 Equity Incentive Plan approved; 3,700,000 new shares reserved (Proposal Four).
- Directors Nelson Chan, Robert Ragusa, Melissa Starovasnik re-elected as Class I directors.
- Non-binding advisory vote on NEO compensation passed with 49.6M votes for; 1.2M against.
- Officer exculpation amendment approved (46.5M for, 4.3M against) effective upon filing Certificate of Amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465925011543/0001104659-25-011543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465925011543/tm255980d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-011543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer